EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 202 filers reported holding EDITAS MEDICINE INC in Q1 2019. The put-call ratio across all filers is 2.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $17,000 | -61.9% | 920 | -15.4% | 0.00% | -50.0% |
| Q3 2021 | $44,654 | -27.5% | 1,087 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $61,568 | +777.8% | 1,087 | +550.9% | 0.00% | – |
| Q1 2021 | $7,014 | -53.9% | 167 | -23.0% | 0.00% | -100.0% |
| Q4 2020 | $15,214 | +224.7% | 217 | +29.9% | 0.00% | – |
| Q3 2020 | $4,686 | -5.1% | 167 | 0.0% | 0.00% | – |
| Q2 2020 | $4,940 | +49.2% | 167 | 0.0% | 0.00% | – |
| Q1 2020 | $3,312 | -33.0% | 167 | 0.0% | 0.00% | – |
| Q4 2019 | $4,945 | +30.2% | 167 | 0.0% | 0.00% | – |
| Q3 2019 | $3,798 | -8.1% | 167 | 0.0% | 0.00% | – |
| Q2 2019 | $4,132 | +1.2% | 167 | 0.0% | 0.00% | – |
| Q1 2019 | $4,083 | -86.8% | 167 | -80.7% | 0.00% | -100.0% |
| Q2 2018 | $30,993 | -4.9% | 865 | -12.0% | 0.00% | 0.0% |
| Q1 2018 | $32,586 | +7.9% | 983 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $30,208 | +28.0% | 983 | 0.0% | 0.00% | +33.3% |
| Q3 2017 | $23,602 | – | 983 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. VI, L.L.C. | 4,656,173 | $160,824,000 | 96.46% |
| Alphabet Inc. | 256,410 | $8,856,000 | 3.65% |
| Casdin Capital, LLC | 85,470 | $2,952,000 | 3.39% |
| Wildcat Capital Management, LLC | 247,768 | $8,558,000 | 2.98% |
| Omega Fund Management, LLC | 105,007 | $3,627,000 | 2.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $59,043,000 | 2.51% |
| EcoR1 Capital, LLC | 87,921 | $3,037,000 | 1.06% |
| Foresite Capital Management III, LLC | 14,500 | $501,000 | 0.39% |
| VIKING GLOBAL INVESTORS LP | 2,135,523 | $73,761,000 | 0.32% |
| Schonfeld Strategic Advisors LLC | 9,726 | $336,000 | 0.14% |